XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.3
Note 15 - Stockholders' Deficit
 9 Months Ended
Sep. 30, 2025
Notes to Financial Statements  
Equity [Text Block]

15. Stockholders' Deficit

 

The following table summarizes stockholders' deficit transactions for the three and nine months ended September 30, 2025 (Dollar amounts in thousands of U.S. dollars): 

 

                  

Accumulated

     
          

Additional

      

other

  

Total

 
  

Common stock

  

paid in

  

Retained earnings

  

comprehensive

  

stockholders'

 
  

Number

  

Amount

  

capital

  

(Accumulated Deficit)

  

income (loss)

  

deficit

 
                         

Balances, June 30, 2025

  11,065,641  $37,429  $21,451  $(180,928) $362  $(121,686)
                         

Stock-based compensation(1)

  24,022   478   961   -   -   1,439 

Net loss

  -   -   -   (23,019)  -   (23,019)

Other comprehensive loss

  -   -   -   -   (793)  (793)

Balances, September 30, 2025

  11,089,663  $37,907  $22,412  $(203,947) $(431) $(144,059)

 

                  

Accumulated

     
          

Additional

      

other

  

Total

 
  

Common stock

  

paid in

  

Retained earnings

  

comprehensive

  

stockholders'

 
  

Number

  

Amount

  

capital

  

(Accumulated Deficit)

  

income (loss)

  

deficit

 
                         

Balances, December 31, 2024

  11,014,655  $36,581  $19,241  $(150,158) $(964) $(95,300)

Exercise of stock options

  -   -   31   -   -   31 

Stock-based compensation(1)

  75,008   1,326   3,140   -       4,466 

Net loss

  -   -   -   (53,789)  -   (53,789)

Other comprehensive loss

  -   -   -   -   533   533 

Balances, September 30, 2025

  11,089,663  $37,907  $22,412  $(203,947) $(431) $(144,059)

 

(1) The Company capitalizes stock-based compensation costs directly attributable to the development of qualifying assets. Qualifying assets include internal use software (“IUS”), assets under construction (“AUC”), equipment, or other long-lived assets that meet the capitalization criteria prescribed by ASC 350. During the three and nine months ended September 30, 2025, the Company capitalized $0.1 million and $0.2 million of stock-based compensation directly attributable to the development of certain IUS assets. During the three and nine months ended September 30, 2024, the Company capitalized $0.1 million and $0.2 million of stock-based compensation directly attributable to the development of certain IUS assets. 

 

2025 Stock Buyback Program 

 

On February 13, 2025, the Company announced that its Board of Directors (“Board”) approved a stock buyback program to repurchase up to $40 million of its common stock in the open market. The $40 million buyback program commenced on February 14, 2025 and is expected to terminate on February 13, 2026. For the three and nine months ended September 30, 2025, the Company did not repurchase shares under this program.

 

2024 Stock Buyback Program

 

On February 22, 2024, the Company announced that its Board has approved a stock buyback program to repurchase up to $40 million of its common stock in the open market. Purchases were to be made exclusively through the facilities of the NASDAQ Capital Market. The stock buyback program commenced on February 23, 2024 and terminated on February 22, 2025. For the nine months ended September 30, 2025 and  September 30, 2024, the Company did not repurchase shares under this program.

 

2023 Stock Buyback Program 

 

On  February 9, 2023, the Company announced that its Board approved a stock buyback program to repurchase up to $40 million of its common stock in the open market. Purchases were to be made exclusively through the facilities of the NASDAQ Capital Market. The stock buyback program commenced on  February 10, 2023 and was terminated on  February 9, 2024. For the nine months ended September 30, 2024 the Company did not repurchase shares under this program.